These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 1361822

  • 1. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E, Kala AR, Grönhagen-Riska C, Ikäheimo R.
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [Abstract] [Full Text] [Related]

  • 2. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC.
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [Abstract] [Full Text] [Related]

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 4. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 5. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T, Ritz E, Passlick-Deetjen J.
    Perit Dial Int; 1996 Aug; 16(3):260-8. PubMed ID: 8761540
    [Abstract] [Full Text] [Related]

  • 6. High-dose calcium carbonate with stepwise reduction in dialysate calcium concentration: effective phosphate control and aluminium avoidance in haemodialysis patients.
    Sawyer N, Noonan K, Altmann P, Marsh F, Cunningham J.
    Nephrol Dial Transplant; 1989 Aug; 4(2):105-9. PubMed ID: 2496350
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E, Bernardini J, Holley J, Chen T, Piraino B.
    Adv Perit Dial; 1993 Aug; 9():280-3. PubMed ID: 8105943
    [Abstract] [Full Text] [Related]

  • 8. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T, Passlick-Deetjen J, Ritz E.
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [Abstract] [Full Text] [Related]

  • 9. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients.
    Wadhwa NK, Howell N, Suh H, Cabralda T.
    Adv Perit Dial; 1992 Mar; 8():385-8. PubMed ID: 1361829
    [Abstract] [Full Text] [Related]

  • 10. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P, Ortega O, Gutiérrez M, Muñoz M, Hilara L, Oliet A, Rodríguez I, Giménez E, Vigil A.
    Nefrologia; 2000 Mar; 20(4):355-61. PubMed ID: 11039261
    [Abstract] [Full Text] [Related]

  • 11. Calcium alginate, an aluminum-free phosphate binder, in patients on CAPD.
    Passlick J, Wilhelm M, Busch T, Grabensee B, Ohnesorge FK.
    Clin Nephrol; 1989 Aug; 32(2):96-100. PubMed ID: 2766587
    [Abstract] [Full Text] [Related]

  • 12. Low calcium (1.25 mmol/L) dialysate can normalize relative hypoparathyroidism in CAPD patients with low bone turnover.
    Shigematsu T, Kawaguchi Y, Kubo H, Nakayama M, Kato N, Yamamoto H, Osaka N, Hayakawa H, Ogawa A, Sakai O.
    Adv Perit Dial; 1996 Aug; 12():250-6. PubMed ID: 8865914
    [Abstract] [Full Text] [Related]

  • 13. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
    Spasovski G, Gelev S, Masin-Spasovska J, Selim G, Sikole A, Vanholder R.
    Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
    [Abstract] [Full Text] [Related]

  • 14. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 15. Low calcium dialysate and hyperparathyroidism.
    Duncan R, Cochrane T, Bhalla C, Michael J, Richards NT, Adu D.
    Perit Dial Int; 1996 Feb; 16 Suppl 1():S499-502. PubMed ID: 8728256
    [Abstract] [Full Text] [Related]

  • 16. Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels.
    Montenegro J, Saracho R, González O, Moina I, Martínez I.
    Clin Nephrol; 1997 Dec; 48(6):359-63. PubMed ID: 9438094
    [Abstract] [Full Text] [Related]

  • 17. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R, Herman A, Ferreira C, Travassos F, Nunes-Azevedo J, Oliveira M.
    Nefrologia; 2002 Dec; 22(5):448-55. PubMed ID: 12497746
    [Abstract] [Full Text] [Related]

  • 18. Low calcium peritoneal dialysis solution. Effects on calcium metabolism and bone disease in CAPD patients.
    Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Santoni O, Pietrucci A.
    ASAIO J; 1992 Dec; 38(3):M593-5. PubMed ID: 1457929
    [Abstract] [Full Text] [Related]

  • 19. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Dec; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 20. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
    Macia M, Coronel F, Navarro JF, Gallego E, Herrero JA, Méndez ML, Chahin J, García J.
    Clin Nephrol; 1997 Sep; 48(3):181-4. PubMed ID: 9342490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.